Safety and Feasibility of Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-/Ibuprofen-Resistant or -Contraindicated Preterm Infants: A Case Series

Background  Although indomethacin and ibuprofen are the standard treatments for hemodynamically significant patent ductus arteriosus (hsPDA), they are associated with renal impairment and gastrointestinal complications. Paracetamol for hsPDA closure does not provoke a peripheral vasoconstrictive eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshima, Ayumi, Matsumura, Shun, Iwatani, Ayaka, Morita, Machiko, Fujinuma, Sumie, Motojima, Yukiko, Tanaka, Kosuke, Masutani, Satoshi, Kabe, Kazuhiko, Ueda, Keiko, Namba, Fumihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical Publishers 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056395/
https://www.ncbi.nlm.nih.gov/pubmed/32140292
http://dx.doi.org/10.1055/s-0040-1702945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056395/
https://www.ncbi.nlm.nih.gov/pubmed/32140292
http://dx.doi.org/10.1055/s-0040-1702945

Ejemplares similares